The 2024 AAA Annual Conference is in Atlanta, Georgia April 17–20 at the Georgia World Congress Center. This four-day event has audiology research and clinical leaders presenting on a wide range of topics. It’s possible to earn up to 3.2 CEUs during the conference while you network and catch up with friends and colleagues. There’s even a special event where you can “Paws and Relax” and meet a new puppy friend!
For current ABA certificate holders, AAA 2024 provides an opportunity to obtain the specialized CEUs required to maintain your certification. As a reminder, here are the CEU requirements for the ABA certificants:
ABAC: At each annual renewal, certificants must meet the following recertification requirements:
- Completion of 20 hours of continuing education, with five of these hours at the Tier 1 level and one hour in professional ethics.
PASC: At the end of each three-year certification cycle, certificants must meet the following recertification requirements:
- Completion of 60 hours of continuing education, with 15 of these hours at the Tier 1 level and three hours in professional ethics.
- 30 of the total 60 continuing education hours must pertain to pediatric audiology.
CISC: At the end of each three-year certification cycle, certificants must meet the following recertification requirements:
- Completion of 60 hours of continuing education, with 15 of these hours at the Tier 1 level and three hours in professional ethics.
- 30 of the total 60 hours of continuing education must pertain to cochlear implants.
Recent Posts
How Do Animals Perceive Music?
Music can be defined as vocal, instrumental, or mechanical sounds, with rhythm, melody or harmony, and often, an expression of human emotion. Music can transcend…
‘Eye’ on Health: AI Detects Dizziness and Balance Disorders Remotely
Interesting research led by audiologist Ali Danesh, PhD, at Florida Atlantic University (FAU) helped develop a novel, proof-of-concept tool to help identify nystagmus using a…
Rizatriptan vs. Placebo for Attacks of Vestibular Migraine: A Randomized Clinical Trial
Jeffrey Staab, MD, and colleagues studied the effectiveness of rizatriptan as a treatment option for vestibular migraine. Their research included 134 patients between the ages of…